Secondary Analyses of Existing Datasets of Tobacco Use and Health (R21 Clinical Trial Not Allowed)

Grant Name
Secondary Analyses of Existing Datasets of Tobacco Use and Health (R21 Clinical Trial Not Allowed)
Funder
HHS-NIH11(National Institutes of Health)
Research Field
Health
Deadline
March 8, 2023 (Expired)
Grant Size
$200,000
Contact Info
National Institutes of Health FBOWebmaster@OD.NIH.GOV
Eligibility
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Others (see text field entitled "Additional Information on Eligibility" for clarification), State governments, Public and State controlled institutions of higher education, Small businesses, Native American tribal governments (Federally recognized), Special district governments, Independent school districts, Native American tribal organizations (other than Federally recognized tribal governments), Private institutions of higher education, Public housing authorities/Indian housing authorities, For profit organizations other than small businesses, City or township governments, County governments, Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Grant Number
RFA-OD-21-003
Description
The purpose of this Funding Opportunity Announcement (FOA) is to invite R21 applications proposing the innovative analysis of existing (publicly available) nationally representative U.S. cross-sectional and longitudinal data, to investigate novel scientific ideas and/or to generate new models, systems, tools, methods, or technologies that have the potential for significant impact on biomedical or biobehavioral research in areas relevant to the Food and Drug Administration (FDA) - Center for Tobacco Products (CTP). Other publicly available data sets would be considered depending on the analyses to be conducted; however, nationally representative analyses will receive priority.

Funding resources

NIH General Instructions Download File
NIH Application Guide Open Link
Purdue Grant Writing Lab: Introduction to Grant Writing Open Link
University of Wisconsin Writing Center: Planning and Writing a Grant Proposal Open Link

Quick share


Add deadline to calendar

March 8, 2023

Have a funding opportunity that you want to list here?

Submit the grant details to support@peeref.com for review and listing.


Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Related opportunities

Open Technology Programme 2023
Earth sciences December 15, 2023 €27,900,000
MRFF Clinical Trials Activity Initiative – 2023 International Clinical Trial Collaborations Grant Opportunity
Medical Research 7-Feb-2024 $12,600,000.00
2023 COVID-19 Aged Care Support Program
Aged Care 3-Apr-2024 $428,780,000.00
NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)
Health Apr 05, 2024 12:00:00 AM EDT $1,000,000
Australian National Aged Care Classification (AN-ACC) Transition Fund
Aged Care 30-Jun-2024 $55,440,000.00
Enhancing Science, Technology, EnginEering, and Math Educational Diversity (ESTEEMED) Research Education Experiences (R25 Clinical Trial Not Allowed)
Health Jan 17, 2025 12:00:00 AM EST $325,000
Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 - Clinical Trial Optional)
Health May 28, 2025 12:00:00 AM EDT $1,500,000
Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed)
Health Sep 05, 2025 12:00:00 AM EDT $300,000
Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)
Health Sep 05, 2025 12:00:00 AM EDT $1,838,436
MOMENTUM (Moving Integrated, Quality Maternal, Newborn, and Child Health and Family Planning and Reproductive Health Services to Scale)
Medicine September 30, 2025 Up to 200,000,000 USD